Stocktoria
Kenvue Inc. KVUE
NYSE · XNYS · stock · Perfumes, Cosmetics & Other Toilet Preparations · website · IPO 2023-05-04
Kenvue Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2023 |
|---|---|---|---|---|
| Revenue | $15.1B | $15.5B | $15.4B | $14.9B |
| Gross profit | $8.8B | $9.0B | $8.6B | $8.3B |
| R&D expense | $382.0M | $408.0M | $399.0M | $375.0M |
| SG&A expense | $6.1B | $6.3B | $6.1B | $5.6B |
| Operating income | $2.4B | $1.8B | $2.5B | $2.7B |
| Interest expense | — | — | $250.0M | $0 |
| Income tax | $529.0M | $385.0M | $526.0M | $573.0M |
| Net income | $1.5B | $1.0B | $1.7B | $2.1B |
| EPS (diluted) | $0.76 | $0.54 | $0.90 | $1.20 |
| Operating cash flow | $2.2B | $1.8B | $3.2B | $2.5B |
| Free cash flow | $1.7B | $1.3B | $2.7B | $2.1B |
| Cash & equivalents | $1.1B | $1.1B | $1.4B | $1.2B |
| Inventory | $1.7B | $1.6B | $1.9B | $2.2B |
| Total assets | $27.1B | $25.6B | $27.9B | $27.3B |
| Total liabilities | $16.3B | $15.9B | $16.6B | $7.3B |
| Shareholders' equity | $10.8B | $9.7B | $11.2B | $20.0B |
Source: SEC EDGAR filings · CIK 0001944048 · as of 2025-12-28. Facts from filings plus Stocktoria's own computed scores — not investment advice.